Acute Vulvovaginal Candidiasis Market Beyond Douching: New Treatment Options Drive the Acute Vulvovaginal Candidiasis Market

Acute Vulvovaginal Candidiasis Market worth $ 485.54 Million by 2030 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acute Vulvovaginal Candidiasis Market- by Drug Type (Clotrimazole, Nystatin, Fluconazole, , Terbinafine, Terconazole and Other Drug Types), Route of Administration (Oral, Intravenous and Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1232

According to the latest research by InsightAce Analytic, the global Acute Vulvovaginal Candidiasis market will be valued at US$ 320.77 Million in 2021. It is expected to reach US$ 485.54 Million by 2030, with a CAGR of 4.8% during a forecast period of 2024-2031.

Acute Vulvovaginal Candidiasis: A Global Market Overview
The acute vulvovaginal candidiasis (VVC) market focuses on the development of various therapies and medications to treat yeast infections caused by the Candida albicans fungus. Also known as vaginal thrush,

VVC causes symptoms like itching, abnormal discharge, and discomfort during sex. An estimated 75% of women will experience VVC at some point in their lives, with some experiencing more severe symptoms like redness, swelling, and vaginal wall tears.

Market Drivers
Several factors are expected to drive the global market for acute vulvovaginal candidiasis over the forecast period:
• Rising Prevalence of VVC: The increasing prevalence of acute vulvovaginal candidiasis worldwide is a major driver of market growth.

• Increased R&D Activities: Pharmaceutical companies are actively engaged in research and development of new VVC treatments and medications, leading to a wider variety of treatment options.

• New Drug Approvals: Competition in the market is pushing companies to obtain regulatory approval for new drug applications (NDAs), which will expand product availability.

Challenges and Considerations
• Impact of COVID-19: The COVID-19 pandemic may have caused disruptions in the market due to factors like resource limitations and healthcare system strain.
Regional Market Analysis

• North America: North America is expected to be a dominant market for acute vulvovaginal candidiasis due to the high prevalence of VVC and established healthcare infrastructure. The United States is the leading market within North America.

• Asia Pacific: The Asia Pacific market is anticipated to experience significant growth in the coming years. This growth is attributed to factors like rising awareness of VVC among women in rural areas and government initiatives promoting hygiene, such as India's "Swachhta, Swasthya, and Suvidha" program.
I hope this revision improves readability by separating the explanation of VVC from the market analysis and highlighting the specific factors driving growth and challenges.

Major market players operating in the Acute Vulvovaginal Candidiasis market include

Mycovia Pharmaceuticals, Inc., Scynexis, Inc., Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Padagis LLC, ProFem GmbH, Amplyx Pharmaceuticals Inc., MethylGene Inc., Ferrer Internacional S.A., Pfizer, Inc., and Other Prominent Players.

Recent collaborations and agreements in the market:
• In February 2021, Scynexis, a biotech business, announced an agreement with Amplity Health, a pharmaceutical company, to extend their support for the commercialization of BrexafemmeTM, a brand name of Ibrexafungerp for vaginal infections, in the United States.

• In October 2019, Mycovia Pharmaceuticals, an American pharmaceutical business, announced a collaboration with Gedeon Richter, a Hungarian pharmaceutical company, to manufacture VT-1161 for the treatment of vulvovaginal candidiasis.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1232

Market Segments
Global Acute Vulvovaginal Candidiasis Market, by Drug Type, 2022-2030 (Value US$ Mn)
• Clotrimazole
• Nystatin
• Fluconazole
• Terbinafine
• Terconazole
• Other Drug Types

Global Acute Vulvovaginal Candidiasis Market, by Route of Administration, 2022-2030 (Value US$ Mn)
• Oral
• Intravenous
• Topical

Global Acute Vulvovaginal Candidiasis Market, by Distribution Channel, 2022-2030 (Value US$ Mn)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Acute Vulvovaginal Candidiasis Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada

Europe Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Acute Vulvovaginal Candidiasis Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Acute Vulvovaginal Candidiasis market
 To receive an industry overview and future trends of the Acute Vulvovaginal Candidiasis market
 To analyze the Acute Vulvovaginal Candidiasis market drivers and challenges
 To get information on the Acute Vulvovaginal Candidiasis market value (US$ Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Acute Vulvovaginal Candidiasis market industry

For More Information @ https://www.insightaceanalytic.com/customisation/1232

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.